HIV topic update: Oro-genital transmission of HIV

Oral Diseases

Volumn 6, Issue 2, 2000, Pages 92-98

  Scully, C ^a   Porter, S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

HIV; Oral; Oro genital; Saliva; Sex

Indexed keywords

ANUS; BODY FLUID; GENITAL SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUTH MUCOSA; MOUTH ULCER; NONHUMAN; PENIS; PRIORITY JOURNAL; REVIEW; SALIVA; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; SPERM; VAGINA MUCOSA; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

EID: 0034069344     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2000.tb00107.x     Document Type: Review

References (133)

1. Akker R van den, Hoek AR, Akker WMR (1992). Detection of HIV antibodies in saliva as a tool for epidemiological studies. AIDS 6: 953-957.
2. Alsip GR, Enchy Y, Sumaya CV et al (1988). Increased Epstein-Barr virus DNA in oropharyngeal secretions from patients with AIDS, AIDS-related complex, or asymptomatic human immunodeficiency virus infections. J Infect Dis 157: 1072-1076.
3. Archibald DW, Barr CE, Torosian JP et al (1987). Secretory IgA antibodies to human immunodeficiency virus in the parotid saliva of patients with AIDS and AIDS-related complex. J Infect Dis 155: 793-796.
4. Archibald DW, Cole GA (1990). In vitro inhibition of HIV-1 infectivity by human salivas. AIDS Res Hum Retroviruses 6: 1425-1432.
5. Archibald DW, Hebert CA, Sun D et al (1990). Salivary antibodies to human immunodeficiency virus type 1 in a phase 1 AIDS vaccine trial. J AIDS 3: 954-958.
6. Archibald DW, Hebert CA (1991). Salivary detection of HIV-1 antibodies using recombinant HIV-1 peptides. Viral Immunol 4: 17-22.
7. Archibald DW, Zon L, Groopman JE et al (1986a). Salivary antibodies as a means of detecting human T cell lymphotropic virus type III/lymphadenopathy-associated virus infection. J Clin Microbiol 24: 873-875.
8. Archibald DW, Zon L, Groopman JE et al (1986b). Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS. Blood 67: 831-834.
9. Atkinson JC, Yeh CK, Oppenheim FG et al (1990). Elevation of salivary antimicrobial proteins following HIV-1 infection. J AIDS 3: 41-48.
10. Baba TW, Trichel AM, An L et al (1996). Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science 272: 1486-1489.
11. Baron S, Cloyd MW (1997). Why is HIV only rarely transmitted normally via the oral cavity? HIV-1 Infection, Mucosal Immunity and Pathogenesis. NIH Abstract, p 50.
12. Baron S, Poast J, Cloyd MW (1999). Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes. Arch Intern Med 159: 303-310.
13. Barr CE, Lopez MR, Rua-Dobles A et al (1992a). HIV-associated oral lesions: immunologic, virologic and salivary parameters. J Oral Pathol Med 21: 295-298.
14. Barr CE, Miller LK, Lopez MR et al (1992b). Recovery of infectious HIV-1 from whole saliva. J Am Dent Assoc 123: 36-48.
15. Barr CE, Qureshi MN, Qui Z et al (1996). Oral HIV-1 recovery in the presence of periodontal disease. Oral Dis 2: 198-201.
16. Behets FM, Edidi B, Quinn TC et al (1991). Detection of salivary HIV-1 specific IgG antibodies in high risk populations in Zaire. J Acquir Immune Defic Synds 4: 183-184.
17. Bergey EJ, Cho MI, Blumberg BM et al (1994). Interaction of HIV-1 and human salivary mucins. J Acquir Immune Defic Synds 7: 995-1002.
18. Bergey EJ, Cho MI, Hammarskjold ML et al (1993). Aggregation of human immunodeficiency virus type 1 by human salivary secretions. Crit Rev Oral Biol Med 4: 467-474.
19. Berry MH, Shea T (1997). Oral sex and HIV transmission. J AIDS 14: 475-477.
20. Black RF (1996). Transmission of HIV-1 in the breast-feeding process. J Am Diet Assoc 96: 267-274.
21. Bosch ML, Schmidt A, Agy MB et al (1997). Rectal but not oral administration of HIV-1 leads to productive infection in pig-tailed macaques. HIV-1 Infection, Mucosal Immunity and Pathogenesis. NIH, Abstract 52.
22. Bratt GA, Berglund T, Glantzberg BL et al (1997). Two cases of oral-to-genital HIV-1 transmission. Int J STD AIDS 8: 522-525.
23. Bukawa H, Sekigawa KI, Hamajima K et al (1995). Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate. Nat Med 1: 681-685.
24. Challacombe SJ, Sweet SP (1997). Salivary and mucosal immune responses to HIV and its co-pathogens. Oral Dis 3 (Suppl 1): S79-S84.
25. Chebbi F. Poveda JD, Suzuki T et al (1997). Search foi infectious HIV in gingival crevicular fluid and saliva of advanced AIDS patients with severe periodontitis. AIDS 11: 927-947.
26. Coppenhaver DH, Srijuktasuth-Woo P. Baron S (1994) Correlation of nonspecific antiviral activity with the ability to isolate infectious HIV-1 from saliva. N Engl J Med 330: 1314-1315.
27. Crofts N, Nicholson S, Coghlan P (1991). Testing of saliva for antibodies to HIV-1. AIDS 5: 561-563.
28. Crombie R, Silverstein RL, MacLow C et al (1998). Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva. J Exp Med 187: 25-35.
29. De Vincenzi I, and European Study Group on Heterosexual Transmission of HIV (1994). A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 331: 341-346.
30. Detels R, English P, Visscher BR et al (1989). Seroconversion, sexual activity, and condom use among 2915 HIV seronegative men followed for up to 2 years. J AIDS 2: 77-83.
31. Dickerson MC, Johnston J, Delea TE et al (1996). The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria. Sex Trans Dis 23: 429-440.
32. Fabris P, Infantolino D. Biasin MR et al (1999). High prevalence of HCV-RNA in the saliva cell fraction of patients with chronic hepatitis C but no evidence of HCV transmission among sexual partners. Infection 27: 86-91.
33. Faruque S, Edlin BR, McCoy CB et al (1996). Crack cocaine smoking and oral sores in three inner-city neighborhoods. J AIDS 13: 87-92.
34. Fox PC, Wolff A, Yeh CK et al (1988). Saliva inhibits HIV-1 infectivity. J Am Dent Assoc 116: 635-637.
35. Fox PC, Wolff A, Yeh CK et al (1989). Salivary inhibition of HIV-1 infectivity: functional properties and distribution in men, women and children. J Am Dent Assoc 118: 709-711.
36. Friedland GH, Saltzman BR, Rogers MF et al (1986). Lack of transmission of HTLV III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med 314: 344-349.
37. Fultz PN, Wolff A, Yeh CK et al (1988). Saliva inhibits HIV-1 infectivity. J Am Dent Assoc 116: 635-637.
38. Fultz PN (1986). Components of saliva inactivate human immunodeficiency virus. Lancet 2: 1215.
39. Gallo D, George JR, Fitchen JH et al (1997). Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. J Am Med Assoc 277: 254-258.
40. Gill SK, Loveday C, Gibson RJC (1992) Transmission of HIV-1 infection by oroanal intercourse. Cenitourin Med 68: 254-257.
41. Gille-Johnson P, Blaxhult A (1996). A case report: HIV sexually transmitted between women. Lakartidningen 93: 3382.
42. Goldberg DJ, Green ST, Kennedy DH et al (1988). HIV and orogenital transmission (letter). Lancet ii: 1363.
43. Goto Y, Yeh CK, Notkins AL et al (1991). Detection of proviral sequences in saliva of patients infected with HIV-1. AIDS Res Human Retroviruses 7: 343-347.
44. Grbic JT, Lamster IB. Mitchell-Lewis D (1997). Inflammatory and immune mediators in crevicular fluid from HIV-infected injecting drug users. J Periodontol 68: 249-255.
45. Grimoud AM, Arnaud C, Dellamonica P et al (1998). Salivary defence factor concentrations in relation to oral and general parameters in HIV positive patients. Eur J Oral Sci 106: 979-985.
46. Groopman JE, Salahuddin SZ, Sarngadharan MG et al (1984). HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS. Science 226: 447-449.
47. Gruer LD, Ssenbaya-Lule G (1993) Sexual behaviour and use of condom by men attending gay bars and clubs in Glasgow and Edinburgh. STD AIDS 4: 95-98.
48. Hart CE, Lennox JL, Pratt-Palmore M et al (1999). Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis 179: 871-882.
49. Ho DD, Byington RE, Schooley RT et al (1985). Infrequency of isolation of HTLV-III virus from saliva in AIDS. N Engl J Med 313: 1606-1610.
50. Huffman JA, Klein H, Clark DC (1997). High risk behavior among crack-using women. Pan-American Conference on AIDS. Lima. Abstract PCV 267.
51. Holmstrom P, Syrjanen S, Laine P et al (1992). HIV antigens detected in gingival fluid. AIDS 6: 738-734.
52. Holmstrom P, Syrjanen S, Laine P et al (1990). HIV antibodies in whole saliva detected by ELISA and Western blot assays. J Med Virol 30: 245-248.
53. Homsy J, Thomson-Honnebier GA, Cheng-Mayer C, Levy JA (1988). Detection of human immunodeficiency virus (HIV) in serum and body fluids by sequential competition ELISA. J Virol Methods 19: 43-56.
54. Hunt AJ, Weatherburn P. Hickson FCI et al (1993). Changes in condom use by gay men. AIDS Care 5: 439-448.
55. Ippolito G, Puro V, Heptonstall J et al (1999). Occupational human immunodeficiency virus infection in health care workers; worldwide cases through September 1997. Clin Infect Dis 28: 365-383.
56. Johnson AM, Wadsworth J, Field J (Eds) (1994). Sexual Attitudes and Lifestyles. Blackwell Scientific Publications: Oxford.
57. Johnson AM, Parry JV, Best SJ et al (1988). HIV surveillance by testing saliva. AIDS 2: 259-271.
58. Kawashima H, Bandyopadhyay S, Rutstein R et al (1991). Excretion of human immunodeficiency type 1 in the throat but not in urine by infected children. J Pediatr 118: 80-82.
59. Keet IP, Albrecht van Lent N, Sandfort TG et al (1992). Orogenital sex and the transmission of HIV among homosexual men. AIDS 6: 223-226.
60. Kennedy S, Davis C, Abrams WR (1998) Submandibular salivary proteasess; lack of a role in anti-HIV activity. J Dent Res 77: 1515-1519.
61. Khajotia RR, Lee E (1997). Transmission of human immunodeficiency virus through saliva after a lip bite. Arch Intern Med 157: 1901.
62. Klein RS, Phelan JA, Freeman K et al (1988). Low occupational risk of human immunodeficiency virus among dental professionals. N Engl J Med 318: 86-90.
63. Koopman JS, Simon CP, Jacquez JA et al (1992). HIV transmission probabilities for oral and anal sex by stage of infection. XIII International Conference on AIDS. Amsterdam, Abstract PoC 4101.
64. Koopman JS, Simon CP, Jacquez JA et al (1989). Selective contact within structured mixing with an application to HIV transmission risk from oral and anal sex. In: Castillo C. ed. Mathematical and Statistical Approaches to AIDS Epidemiology. Springer Verlag: Berlin, pp 111-119.
65. Lamey PJ, Nolan A, Follett EAC et al (1996). Anti-HIV antibody in saliva: an assessment of the role of the components of saliva, testing methodologies and collection systems. J Oral Pathol Med 25: 104-107.
66. Lane HC, Holmberg SD, Jaffe HW (1991). HIV seroconversion and oral intercourse (letter). Am J Public Health 81: 658.
67. Lecatsas G, Houff S, Macher A et al (1985). Retrovirus-like particles in salivary glands, prostate and testes of AIDS patients. Proc Soc Exp Biol Med 178: 653-655.
68. Lifson AR, O'Malley PM, Hessol NA et al (1990). HIV seroconversion in two homosexual men after receptive oral intercourse with ejaculation: implications for counselling concerning safe sexual practices. Am J Public Health 80: 1509-1511.
69. Liuzzi G, Chirianni A, Clementi M et al (1996). Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 10: F51-F56.
70. Lucht E, Albert J, Linde A et al (1993). Human immunodeficiency virus type 1 and cytomegalovirus in saliva. J Med Virol 39: 159-162.
71. Maestro TD, de Vincenzi I (1996). Probabilities of sexual HIV-1 transmission. AIDS 10 (Suppl A): S75-S82.
72. Major CJ, Read SE, Coates RA (1991). Comparison of saliva and blood for human immunodeficiency virus prevalence testing. J Infect Dis 163: 699-702.
73. Malamud D, Davis C, Berthold P et al (1993). Human submandibular saliva aggregates HIV. AIDS Res Human Retroviruses 9: 633-637.
74. Malamud D, Friedman HM (1993). HIV in the oral cavity: virus, viral inhibitory activity and antiviral antibodies. Crit Rev Oral Biol Med 4: 461-466.
75. Marmor M, Weiss LR, Lyden M et al (1986). Possible female to female transmission of human immunodeficiency virus (letter). Ann Intern Med 105: 969.
76. Mayer KH, DeGruttola V (1987). Human immunodeficiency virus and oral intercourse. Ann Intern Med 107: 428-429.
77. McDougal JS, Kennedy MS, Orloff SS et al (1996). Mechanisms of human immunodeficiency virus type 1 (HIV-1) neutralization: irreversible inactivation of infectivity by anti-HIV-1 antibody. J Virol 70: 5236-5245.
78. McNeely TB, Dealy M, Dripps DJ et al (1995). Secretory leukocyte protease inhibitor: a human saliva protein exhibiting antihuman immunodeficiency virus 1 activity in vitro. J Clin Invest 96: 456-464.
79. Milman G, Sharma O (1994) Mechanisms of HIV/SIV mucosal transmission. AIDS Res Human Retroviruses 10: 1305-1312.
80. Monzon OT, Capellan JMB (1987). Female-to-remale transmission of HIV. Lancet ii: 40-41.
81. Moore BE, Flaitz CM, Copenhaver DH et al (1993). HIV recovery from saliva before and after dental treatment: inhibitors may have a critical role in viral inactivation. J Am Dent Assoc 124: 67-74.
82. Muller F, Holmberg-Petersen M, Rollag H et al (1992). Nonspecific oral immunity in individuals with HIV infection. J AIDS 5: 46-51.
83. Muller F, Froland SS, Hvatum M et al (1991). Both IgA subclasses are reduced in parotid saliva from patients with AIDS. Clin Exp Immunol 83: 203-209.
84. Murray AB, Greenhouse PR, Nelson WL et al (1991). Coincident acquisition of Neisseria gonorrhoeae and HIV from fellatio. Lancet 338: 830.
85. Nagashunmugam T, Friedman HM, Davis C et al (1997). Human submandibular saliva specifically inhibits HIV type 1. AIDS Res Human Retroviruses 13: 371-376.
86. Nagashunmugam T, Malamud D, Davis C et al (1998). Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp 120 from the virus. J Infect Dis 178: 1635-1641.
87. Odden K, Schenck K, Hurlen B (1995). High numbers of T cells in gingiva from patients with human immunodeficiency virus (HIV) infection. J Oral Pathol Med 24: 413-419.
88. O'Shea S, Cordery M, Barrett WY et al (1990). HIV excretion patterns and specific antibody responses in body fluids. J Med Virol 31: 291-296.
89. Ostrow DG, DiFranceisco W, Chniel JS (1995). A case control study of human immunodeficiency virus type 1 seroconversions and risk-related behaviors in the Chicago MACS/CCS cohort, 1984-1992. Am J Epidemiol 142: 875-883.
90. Ostrow DG, DiFranceisco W (1996). Why some gay men choose condoms and others switch to "safer" sex. XI International Conference on AIDS. Vancouver, Abstract Tu.D.365.
91. Padian N, Glass S (1997). Transmission of HIV possibly associated with exposure of mucous membrane to contaminated blood. MMWR 46: 620-623.
92. Page-Shafer K, Veuglers PJ, Moss AR et al (1997). Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study 1982-1994. Am J Epidemiol 146: 531-542.
93. Parry JV, Perry KR, Mortimer PP (1987). Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet 2: 72-75.
94. Perry S, Jacobsberg L, Fogel K (1989). Orogenital transmission of human immunodeficiency virus (HIV). Ann Intern Med 111: 951-952.
95. Porter SR, Scully C (1992). Risk of transmission of HIV during dental treatment (Leading Article). Lancet 340: 1259-1260.
96. Pudney J, Oneta M, Mayer K et al (1992). Pre-ejaculatory fluid as a potential vector for sexual transmission of HIV-1 (letter). Lancet 340: 1470.
97. Quatro M, Germinario C, Troiano T et al (1990). HIV transmission by fellatio (letter). Eur J Epidemiol 6: 339-340.
98. Qureshi MN, Barr CE, Hewlitt I et al (1997). Detection of HIV in oral mucosal cells. Oral Dis 3 (Suppl 1): S73-S78.
99. Qureshi MN, Barr CE, Seshamma T et al (1995). Infection of oral mucosal cells by HIV type 2 in seropositive persons. J Infect Dis 171: 190-193.
100. Raiteri R, Fora R, Sinicco A (1994). No HIV-1 transmission through lesbian sex (letter). Lancet 344: 270.
101. Rich JD, Buck A, Tuomata RE et al (1993). Transmission of human immunodeficiency virus presumed to have occurred via female homosexual contact. Clin Infect Dis 17: 1003-1005.
102. Robinovitch MR, Iversen JM, Resnick L (1993). Anti-infectivity of human salivary secretions towards human immunodeficiency virus. Crit Rev Oral Biol Med 4: 455-459.
103. Robinson EK, Evans BG (1999) Oral sex and HIV transmission. AIDS 13: 737-738.
104. Rothenberg RB, Scarlett M, Del Rio C et al (1998). Oral transmission of HIV. AIDS 12: 2095-2105.
105. Royce RA, Sena A, Cates W, Jr et al (1997). Sexual transmission of HIV. N Engl J Med 336: 1072-1078.
106. Rozenbaum W, Gharakhanian S, Cardon B et al (1988). HIV transmission by oral sex (letter) Lancet 1: 1395.
107. Sabatini MT, Patel K, Hirschman R (1984). Kaposi's sarcoma and T-cell lymphoma in an immunodeficient woman: a case report. AIDS Res 1: 135-137.
108. Samuel MC, Hessol NA, Shiboski S et al (1993). Factors associated with human immunodeficiency virus seroconversions in homosexual men in three San Francisco cohort studies. J AIDS 6: 303-312.
109. Schacker T, Collier AC, Hughes J et al (1996). Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 125: 257-264.
110. Schiodt M, Greenspan D, Levy JA et al (1989). Does HIV cause salivary gland disease? AIDS 3: 819-822.
111. Schwarcz SK, Kellogg TA, Kohn RP et al (1995). Temporal trends in human immunodeficiency virus seroprevalence and sexual behavior at the San Francisco municipal sexually transmitted disease clinic, 1989-1992. Am J Epidemiol 142: 314-322.
112. Scully C, Porter SR (1991). The level of risk of transmission of human immunodeficiency virus (HIV) between patients and dental staff. Br Dent J 170: 97-100.
113. Scully C, Samaranayake LP, Martin M (1993). HIV: answers to common questions on transmission, disinfection and antisepsis in clinical dentistry. Br Dent J 175: 175-178.
114. Scully C (1997). HIV topic update: salivary testing for antibodies. Oral Dis 3: 212-215.
115. Shine N, Konopka K, Duzgunes N (1996). The anti-HIV-1 activity associated with saliva. J Dent Res 76: 634-640.
116. Shugars DC, Alexander AL, Fu K et al (1999). Endogenous salivary inhibitors of Human Immunodeficiency Virus. Arch Oral Biol 44: 445-453.
117. Shugars DC, McNeely TB, Eisenberg SP et al (1996). Secretory leukocyte protease inhibitor targets an early event in HIV infection (letter). J Dent Res 75: 114.
118. Shugars DC, Wahl SM (1998). The role of the oral environment in HIV-1 transmission. J Am Dent Assoc 129: 851-858.
119. Skott P, Lucht E, Julander I et al (1999). Salivary sIgA response in HIV-1 infection. J AIDS 21: 73-80.
120. Spitzer PG, Weiner NJ (1989). Transmission of HIV infection from woman to a man by oral sex (letter). N Engl J Med 320: 251.
121. Stahl-Hennig C, Tenner-Racz C, Stolte N et al (1999) The tonsil as a portal of entry for simian immunodeficiency virus (SIV). 15th Annual Symposium on Nonhuman Primate Models for AIDS. Seattle, 1997. Abstract 17.
122. Su HL, Boackle RJ (1991). Interaction of the envelope glycoprotein of human immunodeficiency virus with Clq and fibronectin under conditions present in saliva. Mol Immunol 28: 811-817.
123. Sun D, Archibald DW, Furth PA (1990). Variation of secretory antibodies in parotid saliva to human immunodeficiency virus type 1 with HIV-1 disease stage. AIDS Res Human Retroviruses 6: 933-941.
124. Suzuki T, Tai H, Yoshie H et al (1997). Characterization of HIV-related periodontitis in AIDS patients: HIV-infected macrophage exudate in gingival crevicular fluid as a hallmark of distinctive etiology. Clin Exp Immunol 108: 254-259.
125. Suzuki T, Yoshie H, Jeannel D et al (1996). Detection of intracellular p24-positive macrophages in gingival crevicular fluid from periodontal lesions of stage IV AIDS patients. AIDS 10: 804-805.
126. Troncoso AR, Romani A, Carranza CM et al (1995). Probable HIV transmission by female homosexual contact. Medicina 55: 334-336.
127. Urquia M, Rodriquez-Archilla A, Gonzales-Moles MA et al (1993). Detection of anti-HIV antibodies in saliva. J Oral Pathol Med 22: 153-156.
128. Vidmar L, Poljak M, Tomazic J et al (1996). Transmission of HIV by human bite (letter). Lancet 347: 1762.
129. Wahl SM, Worley P, Jin WW et al (1997a). Anatomic disassociation between HIV-1 and its endogenous inhibitor in mucosal tissues. Am J Pathol 150: 1275-1284.
130. Wahl SM, McNeely TB, Janoff EN et al (1997b). Secretory leukocyte protease inhibitor (SLP1) in mucosal fluids inhibits HIV-1. Oral Dis 3: S64-S69.
131. Wallace JL, Bloch D, Whitmore R et al (1996). Fellatio is a significant risk activity for acquiring AIDS in New York City (NYC) street-walking sex workers. XI International Conference on AIDS. Vancouver Abstract Tu.C.2673.
132. Yeh CK, Handleman B, Fox PC et al (1992). Further studies of salivary inhibition of HIV-1 infectivity. J Acquir Immune Defic Syndr 5: 898-903.
133. Yeung SC, Kazazi F, Randle CG et al (1993). Patients infected with HIV-1 have low levels of virus in saliva even in the presence of periodontal diseases. J Infect Dis 167: 803-809.